Difference between revisions of "Apligraf"
Jump to navigation
Jump to search
m (add interlanguage link) |
m (wikify skin) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | ||
| − | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFweb | + | '''Apligraf''' is a synthetic [[skin]] created from harvested foreskins.<ref>{{REFweb |
|quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | |quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | ||
|url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | |url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ | ||
| Line 18: | Line 18: | ||
|date= | |date= | ||
|accessdate=2011-03-06 | |accessdate=2011-03-06 | ||
| − | }}</ref> and it is made and sold by [[Organogenesis]], | + | }}</ref> and it is made and sold by [[Organogenesis]], a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. |
== Apligraph Oral == | == Apligraph Oral == | ||
| Line 32: | Line 32: | ||
|accessdate=2011-12-20 | |accessdate=2011-12-20 | ||
}}</ref> | }}</ref> | ||
| − | + | <!-- 404: Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf --> | |
| − | Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf | ||
| − | |||
{{REF}} | {{REF}} | ||
| − | [[Category:Foreskin | + | [[Category:Foreskin product]] |
[[Category:Financial gain]] | [[Category:Financial gain]] | ||
Latest revision as of 15:56, 27 December 2021
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
